MIAMI - ColoradoDesk -- First Choice Neurology, the nation's largest single-specialty private neurology provider, announces the launch of Neuro2Go, an on-demand face-to-face chat service that offers health consumers everywhere the opportunity to discuss a neurologic concern with a board-certified adult or pediatric neurologist.

This differs from a traditional office or telehealth encounter, whereby a patient is scheduled, insurance is utilized, and there is a comprehensive medical history and physical examination typically followed by complex medical decision making.

Neuro2Go bypasses all this, providing individuals quick and affordable access to nationally recognized neurologists who will provide up-to-the-minute neurologic information and next-step recommendations.

No insurance is used or required.  A fee of $95 is paid by the customer at the time of scheduling. Same and next weekday appointments are available.

Worries about a family member with memory loss, persistent headache, dizziness, recent seizure, COVID-19 long haulers, or any adult or pediatric neurologic condition are quickly addressed in this face-to-face audiovisual encounter.

More on Colorado Desk

• Governor Polis Celebrates Strong International Partnership at Japan America Society of Colorado Annual Gala
• HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
• Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
• OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
• P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport

Dr. Jeff Gelblum, a board member of First Choice Neurology, states that "Neuro2Go provides everyone immediate access to our team of top-notch neurologists to rapidly address a neurologic concern. Individuals without health insurance or who don't have the opportunity to schedule a regular in-person or telehealth appointment can have their issue addressed quickly with appropriate recommendations for further evaluation."

Since the launch a few weeks ago, the Neuro2Go website has been busy scheduling individuals for next-day face-to-face encounters to address their concerns of memory loss, persistent headaches, childhood seizures, dizziness, pain, long haulers, and everything neurologic.

Gelblum states that "folks are happy to pay $95 for easy access to a board-certified neurologist to have their immediate worries addressed.  If the situation warrants, these individuals are scheduled into one of our 41 offices for traditional neurologic evaluation and management.  If the patient resides far away, we provide recommendations for further assessment in their community."

More on Colorado Desk

• DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
• Boulder SEO Marketing Founder Takes the Agency Automation Gap to AgencyCon 2026
• Colorado: Bustang Adds On-Demand Visual and ASL Interpreting for Blind, Low Vision, Deaf, and Hard of Hearing Riders
• Supporting Colorado's Cultural Legacy: 25 New Folk and Traditional Arts Initiatives Awarded Across the State
• French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service

First Choice Neurology has been approached by hospital networks, employer organizations, and pharmaceutical companies to interface the Neuro2Go platform to their customers. Gelblum is excited about this new trend of consumer-focused health care which is affordable, quick, and not weighed down by insurance constraints.  He believes that Neuro2Go will "markedly transform the delivery paradigm of neurologic health care."

About First Choice Neurology

First Choice Neurology is the largest neurology group in the United States with more than 41 facilities in 6 Florida counties and services at 35 major hospitals. For additional information about First Choice Neurology, visit the website at https://www.fcneurology.net. To learn more about Neuro2Go, visit https://neuro2go.com.